Sodium fluoride 0.55 MG Chewable Tablet — RxCUI 198215
RxNorm drug concept · Semantic clinical drug
RxCUI 198215
Semantic clinical drug · SCD
● Current RxNorm concept 8 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198215
Official nameSodium fluoride 0.55 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assodium fluoride 0.55 MG (fluoride ion 0.25 MG) Chewable Tablet; fluoride 0.25 MG Chewable Tablet
FDA products mapped8
Package NDCs mapped9
Reported Medicaid activity (SDUD)78,889 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Sodium fluoride 0.55 MG Chewable Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sodium fluoride 0.55 MG Chewable Tablet
RxCUI 198215 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sodium fluoride
9873IN
-
Sodium fluoride
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Epiflur
894943BN -
Ludent
901277BN
-
Epiflur
-
Dose forms 16
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sodium fluoride Chewable Tablet
373907SCDF -
Sodium fluoride Chewable Product
1295174SCDG -
Sodium fluoride Oral Product
1159341SCDG -
Sodium fluoride Pill
1159343SCDG -
Sodium fluoride Chewable Tablet [Epiflur]
894945SBDF -
Sodium fluoride Chewable Tablet [Ludent]
901279SBDF -
Epiflur Chewable Product
1296134SBDG -
Epiflur Oral Product
1167610SBDG - +8 more in this family
-
Sodium fluoride Chewable Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sodium fluoride 0.55 MG
336808SCDC -
Sodium fluoride 0.55 MG Chewable Tablet [Epiflur]
999476SBD -
Sodium fluoride 0.55 MG Chewable Tablet [Ludent]
901280SBD -
Sodium fluoride 0.55 MG [Epiflur]
999475SBDC -
Sodium fluoride 0.55 MG [Ludent]
901278SBDC
-
Sodium fluoride 0.55 MG
Showing up to 8 concepts per family — 16 of 24 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sodium fluoride 0.55 MG
SCDC · 336808 -
Sodium fluoride Chewable Tablet
SCDF · 373907 -
Sodium fluoride Chewable Product
SCDG · 1295174 -
Sodium fluoride Oral Product
SCDG · 1159341 -
Sodium fluoride Pill
SCDG · 1159343
Brand-Name Concepts
-
Sodium fluoride 0.55 MG Chewable Tablet [Epiflur]
SBD · 999476 -
Sodium fluoride 0.55 MG Chewable Tablet [Ludent]
SBD · 901280 -
Sodium fluoride 0.55 MG [Epiflur]
SBDC · 999475 -
Sodium fluoride 0.55 MG [Ludent]
SBDC · 901278 -
Sodium fluoride Chewable Tablet [Epiflur]
SBDF · 894945 -
Sodium fluoride Chewable Tablet [Ludent]
SBDF · 901279 -
Epiflur Chewable Product
SBDG · 1296134 -
Epiflur Oral Product
SBDG · 1167610 -
Epiflur Pill
SBDG · 1167611 -
Ludent Chewable Product
SBDG · 1296339
📦 FDA Products & Package NDCs
8 products · 9 package NDCs
9 package NDCs map to RxCUI 198215 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 58657-0160-12 | 120 TABLET in 1 BOTTLE (58657-160-12) | Sodium Fluoride Chewable | Method Pharmaceuticals, LLC | 2018-08-17 |
| 58657-0161-10 | 1000 TABLET in 1 BOTTLE (58657-161-10) | Sodium Fluoride Chewable | Method Pharmaceuticals, LLC | 2018-08-17 |
| 58657-0161-12 | 120 TABLET in 1 BOTTLE (58657-161-12) | Sodium Fluoride Chewable | Method Pharmaceuticals, LLC | 2018-08-17 |
| 58657-0162-12 | 120 TABLET in 1 BOTTLE (58657-162-12) | Sodium Fluoride Chewable | Method Pharmaceuticals, LLC | 2018-08-17 |
| 63629-1130-01 | 120 TABLET in 1 BOTTLE (63629-1130-1) | Sodium Fluoride Chewable | Bryant Ranch Prepack | 2020-10-21 |
| 72162-1652-02 | 120 TABLET in 1 BOTTLE (72162-1652-2) | Sodium Fluoride Chewable | Bryant Ranch Prepack | 2024-04-04 |
| 75826-0163-20 | 120 TABLET, CHEWABLE in 1 BOTTLE (75826-163-20) | Fluoride | WINDER LABORATORIES, LLC | 2024-01-01 |
| 75826-0164-20 | 120 TABLET, CHEWABLE in 1 BOTTLE (75826-164-20) | Fluoride | WINDER LABORATORIES, LLC | 2024-01-01 |
| 75826-0165-20 | 120 TABLET, CHEWABLE in 1 BOTTLE (75826-165-20) | Fluoride | WINDER LABORATORIES, LLC | 2024-01-01 |
Observed labelers:
Method Pharmaceuticals, LLC (4) ·
WINDER LABORATORIES, LLC (3) ·
Bryant Ranch Prepack (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.